BEACON (BEd bAnd proof of CONcept )

高质量的睡眠是必不可少的，对健康和福祉有重大影响。全球有超过17亿人患有多发性硬化症、关节炎和肌肉营养不良等肌肉骨骼疾病，超过7700万人在中风中幸存下来。对于患有上述条件的人来说，行动不便是很常见的，这可能会阻碍他们每晚获得高质量的睡眠，从而导致直接和间接的医疗成本。缺乏良好的睡眠质量和数量可能会导致进一步的健康问题，如认知问题、高血压、心血管疾病和焦虑和抑郁的发病率增加。_2020年全球睡眠辅助设备的市场为496.2亿GB，预计到2030年这一数字将上升到928.2亿GB\。床垫和枕头是市场上最有利可图的助眠产品。BEACON将证明并启用Bed Band，这是一种正在申请专利的健康和福利设备，采用以人为本的解决方案，利用先进的制造和材料开发，可以改善那些努力保持舒适卧姿的人的睡眠质量。该设备帮助用户减少失眠、疼痛和不适的发生率，从而改善睡眠并降低护理成本。仅Bed Band一项针对行动不便人群的英国潜在市场就超过1100万人。Beacon项目将评估由于不适而难以获得良好睡眠的行动不便患者的Bed Band-我们将使用经过验证的睡眠监测技术和用户调查来衡量睡眠的数量和质量-结果将支持2023年前的商业化

High quality sleep is essential and has a major impact on health and wellbeing.Globally, over 1.7 billion people have musculoskeletal conditions such as multiple sclerosis, arthritis, and muscular dystrophy and over 77 million have survived a stroke. It is common for people with the conditions listed to have mobility limitations that can prevent them from achieving high-quality sleep each night, resulting in direct and indirect healthcare costs. Lack of good quality and quantity of sleep can lead to further health issues, such as cognition problems, high blood pressure, cardiovascular disease and increased incidence of anxiety and depression_._ The market for sleep aids globally is £49.62 billion in 2020, this figure is predicted to rise to £92.82 billion by 2030\. With mattresses and pillows being the most lucrative form of sleep aid on the market.BEACON will evidence and enable the Bed Band, a patent-pending health and wellbeing device developed using advanced manufacturing and materials by Person Centred Solutions that improves sleep quality for people who struggle to maintain a comfortable position in bed. The device helps users reduce their incidence of insomnia, pain, and discomfort resulting in improved sleep and lower costs of care. The UK addressable market for people with mobility limitations alone for the Bed Band exceeds 11 million people. The BEACON project will evaluate the Bed Band in people with mobility issues who struggle to get a good night's sleep due to discomfort-We will measure the amount and quality of sleep using validated sleep monitoring technology and user surveys-Results will support commercialisation by 2023